Cargando…
Novel Therapeutic GPCRs for Psychiatric Disorders
G protein-coupled receptors (GPCRs) are the most common targets of the neuropharmacological drugs in the central nervous system (CNS). GPCRs are activated by manifold neurotransmitters, and their activation in turn evokes slow synaptic transmission. They are deeply involved in multiple neurological...
Autor principal: | Komatsu, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490542/ https://www.ncbi.nlm.nih.gov/pubmed/26101869 http://dx.doi.org/10.3390/ijms160614109 |
Ejemplares similares
-
Psychiatric Neural Networks and Precision Therapeutics by Machine Learning
por: Komatsu, Hidetoshi, et al.
Publicado: (2021) -
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma
por: Raymond, Jérémy H., et al.
Publicado: (2022) -
Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders
por: Komatsu, Hidetoshi, et al.
Publicado: (2019) -
Advancements in therapeutically targeting orphan GPCRs
por: Stockert, Jennifer A., et al.
Publicado: (2015) -
Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?
por: Cosín-Roger, Jesús, et al.
Publicado: (2020)